Form 4: Vir Biotechnology EVP Ann Hanly Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Ann M. Hanly, EVP & Chief Technology Officer of Vir Biotechnology, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 24, 2025, Ann M. Hanly, EVP & Chief Technology Officer of Vir Biotechnology, Inc., sold 14,168 shares of common stock at a price of $9.4534 per share.
- The sale was executed to cover the issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- Following the transaction, Hanly directly owns 117,901 shares of Vir Biotechnology, Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Date of stock sale transaction. |
| 02/25/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.